These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32680842)

  • 1. HIV postexposure prophylaxis during the COVID-19 pandemic: experience from Madrid.
    Sánchez-Rubio J; Vélez-Díaz-Pallarés M; Rodríguez González C; Sanmartin Fenollera P; García Yubero C; García-Valdecasas MF
    Sex Transm Infect; 2021 Mar; 97(2):100. PubMed ID: 32680842
    [No Abstract]   [Full Text] [Related]  

  • 2. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on HIV nonoccupational postexposure prophylaxis.
    Koyama A; Middlebrooks L; Bullock A
    Curr Opin Pediatr; 2019 Aug; 31(4):454-461. PubMed ID: 30985387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When is postexposure prophylaxis recommended for needlestick?
    Matin M; Goldschmidt RH
    Am Fam Physician; 2011 Jun; 83(12):1374. PubMed ID: 21671536
    [No Abstract]   [Full Text] [Related]  

  • 5. Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis.
    Tan DHS; Hull MW; Yoong D; Tremblay C; O'Byrne P; Thomas R; Kille J; Baril JG; Cox J; Giguere P; Harris M; Hughes C; MacPherson P; O'Donnell S; Reimer J; Singh A; Barrett L; Bogoch I; Jollimore J; Lambert G; Lebouche B; Metz G; Rogers T; Shafran S;
    CMAJ; 2017 Nov; 189(47):E1448-E1458. PubMed ID: 29180384
    [No Abstract]   [Full Text] [Related]  

  • 6. Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.
    Tissot F; Erard V; Dang T; Cavassini M
    HIV Med; 2010 Oct; 11(9):584-92. PubMed ID: 20345883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Announcement: Updated Guidelines for Antiretroviral Postexposure Prophylaxis after Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV - United States, 2016.
    MMWR Morb Mortal Wkly Rep; 2016 May; 65(17):458. PubMed ID: 27149423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual HIV pre-exposure prophylaxis outpatient service in the era of COVID-19.
    Quirke S; Quinn L; Hegarty D; Loy A; Lyons F; Mulcahy F; Devitt E
    Int J STD AIDS; 2021 Jan; 32(1):100-103. PubMed ID: 33050787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Postexposure Prophylaxis Starter Packs Were Not Designed to Help or Hinder Adherence.
    Zimmer R
    Clin Infect Dis; 2016 Mar; 62(5):667-8. PubMed ID: 26582746
    [No Abstract]   [Full Text] [Related]  

  • 10. Counselling improves follow-up HIV testing at Week 6 for HIV postexposure prophylaxis recipients.
    Farrugia Parsons B; Fisher K; Cordery D; Couldwell D
    Sex Health; 2013 Jul; 10(3):288-9. PubMed ID: 23557699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of HIV for persons with low-frequency, high-risk exposures: PrEP (preexposure prophylaxis), PEP (postexposure prophylaxis), or 'PIP' (postexposure prophylaxis in-pocket).
    Wood BR
    AIDS; 2020 Mar; 34(3):481-482. PubMed ID: 31996596
    [No Abstract]   [Full Text] [Related]  

  • 12. Adherence to HIV Postexposure Prophylaxis in a Major Hospital in Northwestern Nigeria.
    Dayyab FM; Iliyasu G; Habib AG
    Infect Control Hosp Epidemiol; 2018 Feb; 39(2):247-248. PubMed ID: 29291753
    [No Abstract]   [Full Text] [Related]  

  • 13. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic.
    Saberi P; Ming K; Hojilla JC; Scott HM; Neilands TB
    J Acquir Immune Defic Syndr; 2021 May; 87(1):e173-e176. PubMed ID: 33534275
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury.
    Borba Brum MC; Dantas Filho FF; Yates ZB; Verçoza Viana MC; Martin Chaves EB; Trindade DM
    Am J Infect Control; 2013 May; 41(5):471-2. PubMed ID: 23084562
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes to Initial Postexposure Prophylaxis Regimens Between the Emergency Department and Clinic.
    Bogoch II; Siemieniuk RA; Andrews JR; Scully EP; Mayer KH; Bell CM; Zachary KC; Yawetz S
    J Acquir Immune Defic Syndr; 2015 Aug; 69(5):e182-4. PubMed ID: 25967272
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of the 2011 UK post-exposure prophylaxis for HIV following sexual exposure guidelines: a regional retrospective audit.
    Bennett A; Wainwright E; Lord E; Oduru M; Chen F; Desmond N; Sherrard J; Duncan S
    Int J STD AIDS; 2015 Sep; 26(10):746-8. PubMed ID: 25332226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an Intervention to Increase Occupational Postexposure Prophylaxis in Sub-Saharan Africa.
    Courtenay-Quirk C; Selenic D; Lahuerta M; Kassa G; Murrman M; Bock N
    J Assoc Nurses AIDS Care; 2016; 27(5):727-30. PubMed ID: 27425796
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
    Rubin R
    JAMA; 2023 Mar; 329(12):963-964. PubMed ID: 36857098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV postexposure prophylaxis-in-pocket.
    Billick M; Bogoch II
    CMAJ; 2024 Jul; 196(24):E826. PubMed ID: 38955414
    [No Abstract]   [Full Text] [Related]  

  • 20. Brazil sustains HIV response during the COVID-19 pandemic.
    Pereira GFM
    Lancet HIV; 2021 Feb; 8(2):e65. PubMed ID: 33539759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.